Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-11-27, Stock:NVS, The news for the past five days is as follows:
2020-11-19: NEWS1: Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy.NEWS2: Price Over Earnings Overview: Novartis.NEWS3: New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases.NEWS4: Novartis set to achieve 100% renewable electricity in its European operations.
2020-11-20: NEWS1: Why Mesoblast Stock Is Blasting Off Today.NEWS2: Novartis (NVS) Partners With Mesoblast for ARDS Cell Therapy.NEWS3: Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More.NEWS4: 20 Largest European Companies By Market Cap in 2020.NEWS5: The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger.
2020-11-23: nan
2020-11-24: NEWS1: The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia.NEWS2: Novartis Kicks Off $2.5B Share Buyback Program On Strong Pipeline Growth.NEWS3: Novartis highlights confidence in growing sales with margin expansion, fueled by in-market brands and a rich pipeline, at Annual Meet the Management investor event.NEWS4: Mesoblast (MESO) Q1 2021 Earnings Call Transcript.
2020-11-25: NEWS1: Should Value Investors Consider Novartis (NVS) Stock Now?.

Answer: Rise